Russell H. Wiesner
#103,207
Most Influential Person Now
Russell H. Wiesner's AcademicInfluence.com Rankings
Russell H. Wiesnerphilosophy Degrees
Philosophy
#4108
World Rank
#6501
Historical Rank
Logic
#1642
World Rank
#2444
Historical Rank

Russell H. Wiesnermathematics Degrees
Mathematics
#5058
World Rank
#7154
Historical Rank
Statistics
#307
World Rank
#369
Historical Rank

Download Badge
Philosophy Mathematics
Russell H. Wiesner's Degrees
- PhD Biostatistics University of California, Berkeley
- Doctorate Medicine University of California, San Francisco
Why Is Russell H. Wiesner Influential?
(Suggest an Edit or Addition)Russell H. Wiesner's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- A model to predict survival in patients with end‐stage liver disease (2001) (2667)
- Model for end-stage liver disease (MELD) and allocation of donor livers. (2003) (2252)
- A model to predict survival in patients with end-stage liver disease. (2001) (1889)
- Banff schema for grading liver allograft rejection: An international consensus document (1997) (1152)
- Hyponatremia and mortality among patients on the liver-transplant waiting list. (2008) (944)
- MELD and PELD: Application of survival models to liver allocation (2001) (826)
- The new liver allocation system: Moving toward evidence‐based transplantation policy (2002) (654)
- Evidence-based incorporation of serum sodium concentration into MELD. (2006) (638)
- Primary sclerosing cholangitis: Natural history, prognostic factors and survival analysis (1989) (588)
- Predictors of patient and graft survival following liver transplantation for hepatitis C (1998) (570)
- Pulmonary hemodynamics and perioperative cardiopulmonary‐related mortality in patients with portopulmonary hypertension undergoing liver transplantation (2000) (513)
- Epstein-barr virus-induced posttransplant lymphoproliferative disorders (1999) (475)
- MELD accurately predicts mortality in patients with alcoholic hepatitis (2005) (463)
- Acute hepatic allograft rejection: Incidence, risk factors, and impact on outcome (1998) (456)
- Update of the International Banff Schema for liver allograft rejection: Working recommendations for the histopathologic staging and reporting of chronic rejection (2000) (452)
- Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. (1994) (438)
- Report of the First International Liver Transplantation Society Expert Panel Consensus Conference on Liver Transplantation and Hepatitis C (2003) (426)
- Results of the first year of the new liver allocation plan (2004) (425)
- Natural history of hepatopulmonary syndrome: Impact of liver transplantation (2005) (415)
- Ischemic‐type biliary complications after orthotopic liver transplantation (1992) (415)
- Clinicopathologic features of the syndrome of primary sclerosing cholangitis (1980) (389)
- Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. (1997) (381)
- Pretransplantation assessment of the risk of lymphoproliferative disorder. (1995) (377)
- A revised natural history model for primary sclerosing cholangitis. (1997) (349)
- Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis. (1991) (334)
- Portopulmonary hypertension: Results from a 10‐year screening algorithm (2006) (316)
- Primary sclerosing cholangitis: findings on cholangiography and pancreatography. (1983) (301)
- Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis (1991) (299)
- Long‐term results of patients undergoing liver transplantation for primary sclerosing cholangitis (1999) (297)
- Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. (1998) (297)
- Recurrence of primary sclerosing cholangitis following liver transplantation (1999) (296)
- Use of fatty donor liver is associated with diminished early patient and graft survival. (1996) (295)
- Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis (1981) (290)
- TT‐virus infection in north american blood donors, patients with fulminant hepatic failure, and cryptogenic cirrhosis (1998) (289)
- Whipple's disease: clinical, biochemical, and histopathologic features and assessment of treatment in 29 patients. (1988) (276)
- Survival in Portopulmonary Hypertension: Mayo Clinic Experience Categorized by Treatment Subgroups (2008) (275)
- Liver transplantation for hepatocellular cancer: the impact of the MELD allocation policy. (2004) (271)
- Current concepts in primary sclerosing cholangitis. (1984) (264)
- Risk Factors for and Clinical Course of Non‐Anastomotic Biliary Strictures After Liver Transplantation (2003) (260)
- A randomized double‐blind comparative study of mycophenolate mofetil and azathioprine in combination with cyclosporine and corticosteroids in primary liver transplant recipients (2001) (256)
- Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): A study of 15 patients with moderate to severe portopulmonary hypertension (1999) (255)
- Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease (2001) (250)
- Primary sclerosing cholangitis: refinement and validation of survival models. (1992) (248)
- Evolving Frequency and Outcomes of Liver Transplantation Based on Etiology of Liver Disease (2013) (248)
- Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease. (2000) (247)
- Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations. (1995) (246)
- Improving liver allocation: MELD and PELD (2004) (245)
- Frequency and clinical implications of increased pulmonary artery pressures in liver transplant patients. (1996) (245)
- Liver transplantation for hepatocellular carcinoma: The MELD impact (2004) (245)
- Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C (2002) (241)
- Incidence, distribution, and outcome of episodes of infection in 100 orthotopic liver transplantations. (1989) (236)
- Hepatopulmonary syndrome: a prospective study of relationships between severity of liver disease, PaO(2) response to 100% oxygen, and brain uptake after (99m)Tc MAA lung scanning. (2000) (231)
- Efficacy of liver transplantation in patients with primary biliary cirrhosis. (1989) (221)
- A long-term comparison of tacrolimus (FK506) versus cyclosporine in liver transplantation: a report of the United States FK506 Study Group. (1998) (214)
- Diagnosis and Monitoring of Whipple Disease by Polymerase Chain Reaction (1997) (214)
- Combined Liver Transplantation and Gastric Sleeve Resection for Patients With Medically Complicated Obesity and End‐Stage Liver Disease (2013) (214)
- Intrapulmonary vascular dilatations (IPVD) in liver transplant candidates. Screening by two-dimensional contrast-enhanced echocardiography. (1990) (214)
- MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients (2004) (212)
- Hepatopulmonary syndrome with progressive hypoxemia as an indication for liver transplantation: case reports and literature review. (1997) (209)
- Diagnostic features and clinical outcome of ischemic‐type biliary complications after liver transplantation (1993) (204)
- Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantation (2000) (199)
- Weight change and obesity after liver transplantation: incidence and risk factors. (1998) (198)
- A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis. (1990) (195)
- Quality of life before and after liver transplantation for cholestatic liver disease (1999) (193)
- Risk factors of invasive Candida and non-Candida fungal infections after liver transplantation. (1996) (192)
- Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation (1998) (189)
- Bone disease in liver transplant recipients: incidence, timing, and risk factors. (1991) (187)
- Diagnostic role of serum CA 19-9 for cholangiocarcinoma in patients with primary sclerosing cholangitis. (1993) (184)
- Accuracy of doppler echocardiography in the assessment of pulmonary hypertension in liver transplant candidates (2000) (183)
- Comparison of the clinicopathologic features of primary sclerosing cholangitis and primary biliary cirrhosis. (1985) (183)
- Cyclosporine-induced hypertension after transplantation. (1994) (182)
- Prospective evaluation of esophageal varices in primary biliary cirrhosis: development, natural history, and influence on survival. (1989) (182)
- The acute vanishing bile duct syndrome (acute irreversible rejection) after orthotopic liver transplantation (1987) (181)
- Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. (1997) (181)
- Hepatobiliary carcinoma associated with primary sclerosing cholangitis and chronic ulcerative colitis. (1985) (180)
- Recurrent autoimmune hepatitis after orthotopic liver transplantation (2001) (179)
- Gallbladder disease in patients with primary sclerosing cholangitis. (1988) (173)
- Evolution of cardiovascular risk after liver transplantation: a comparison of cyclosporine A and tacrolimus (FK506). (1997) (172)
- Increased Bile Duct Complications in Liver Transplantation Across the ABO Barrier (1993) (171)
- Differential Effects of Donor Age in Liver Transplant Recipients Infected With Hepatitis B, Hepatitis C and Without Viral Hepatitis (2005) (171)
- MELD and Other Factors Associated with Survival after Liver Transplantation (2004) (170)
- Prognostic features and role of liver transplantation in severe corticosteroid‐treated autoimmune chronic active hepatitis (1992) (170)
- Resource utilization in liver transplantation: effects of patient characteristics and clinical practice. NIDDK Liver Transplantation Database Group. (1999) (168)
- Summary report of a national conference: Evolving concepts in liver allocation in the MELD and PELD era (2004) (164)
- Assessment of nutritional status of patients with end-stage liver disease undergoing liver transplantation. (1989) (159)
- Recurrence of nonalcoholic steatohepatitis following liver transplantation. (1996) (157)
- Prospective trial of penicillamine in primary sclerosing cholangitis. (1988) (154)
- Trial of penicillamine in advanced primary biliary cirrhosis. (1985) (154)
- Long‐term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation (2007) (153)
- Clinicopathologic features of the syndrome of primary sclerosing cholangitis. (1980) (152)
- Idiopathic adulthood ductopenia. A cause of chronic cholestatic liver disease and biliary cirrhosis. (1988) (151)
- Cytomegalovirus hepatitis in liver transplantation: prospective analysis of 93 consecutive orthotopic liver transplantations. (1989) (150)
- Chronic renal dysfunction late after liver transplantation (2002) (148)
- SYSTEMIC AND RENAL HEMODYNAMIC DIFFERENCES BETWEEN FK506 AND CYCLOSPORINE IN LIVER TRANSPLANT RECIPIENTS (1993) (147)
- Risk factors for cytomegalovirus and severe bacterial infections following liver transplantation: a prospective multivariate time-dependent analysis. (1993) (146)
- FK506‐induced neurotoxicity in liver transplantation (1994) (145)
- Selection and timing of liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitis (1992) (142)
- Age and liver transplantation: a report of the Liver Transplantation Database. (1998) (142)
- Current concepts in cell‐mediated hepatic allograft rejection leading to ductopenia and liver failure (1991) (142)
- Post‐Transplant Lymphoproliferative Disorders Following Liver Transplantation: Incidence, Risk Factors and Survival (2006) (141)
- Neurotoxicity in liver transplant recipients with cyclosporine immunosuppression (1995) (141)
- SELECTIVE BOWEL DECONTAMINATION TO DECREASE GRAM‐NEGATIVE AEROBIC BACTERIAL AND CANDIDA COLONIZATION AND PREVENT INFECTION AFTER ORTHOTOPIC LIVER TRANSPLANTATION (1988) (140)
- Effect of proctocolectomy for chronic ulcerative colitis on the natural history of primary sclerosing cholangitis. (1989) (136)
- A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue Study Group. (1996) (133)
- Peristomal varices after proctocolectomy in patients with primary sclerosing cholangitis. (1986) (132)
- Preemptive use of oral ganciclovir to prevent cytomegalovirus infection in liver transplant patients: a randomized, placebo-controlled trial. (2002) (132)
- Report of the first international liver transplantation society expert panel consensus conference on renal insufficiency in liver transplantation (2009) (130)
- OKT3 treatment for allograft rejection is a risk factor for cytomegalovirus disease in liver transplantation. (1995) (129)
- Floxuridine‐induced sclerosing cholangitis: An ischemic cholangiopathy? (1989) (129)
- Patients with asymptomatic primary sclerosing cholangitis frequently have progressive disease. (1990) (125)
- The relative role of the child‐pugh classification and the mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis (1999) (125)
- Mycophenolate mofetil combination therapy improves long‐term outcomes after liver transplantation in patients with and without hepatitis C (2005) (125)
- Treatment of posttransplantation recurrence of hepatitis C with interferon and ribavirin: Lessons on tolerability and efficacy (2002) (124)
- A Pilot Study of the Safety and Tolerability of Etanercept in Patients with Alcoholic Hepatitis (2004) (123)
- Diminished survival in asymptomatic primary biliary cirrhosis. A prospective study. (1990) (123)
- Hepatopulmonary syndrome: Favorable outcomes in the MELD exception era (2013) (123)
- Seroconversion to human herpesvirus 6 following liver transplantation is a marker of cytomegalovirus disease. (1997) (123)
- Preoperative hepatic artery chemoembolization followed by orthotopic liver transplantation for hepatocellular carcinoma. (1999) (123)
- The combination of prednisone and colchicine in patients with primary sclerosing cholangitis. (1991) (121)
- The clinical course of transplantation-associated de novo hepatitis B infection in the liver transplant recipient. (1997) (121)
- Insulin Resistance, Serum Adipokines and Risk of Fibrosis Progression in Patients Transplanted for Hepatitis C (2009) (120)
- Hilar biliary strictures after liver transplantation: cholangiography and percutaneous treatment. (1990) (119)
- Recurrence of primary biliary cirrhosis after liver transplantation: Histologic estimate of incidence and natural history (2003) (119)
- The first 100 liver transplantations at the Mayo Clinic. (1989) (118)
- Immunohistochemical characterization of hepatic lymphocytes in primary biliary cirrhosis in comparison with primary sclerosing cholangitis and autoimmune chronic active hepatitis. (1993) (116)
- Increased risk of chronic liver failure in adults with heterozygous α‐antitrypsin deficiency (1998) (115)
- Predicting Survival among Patients Listed for Liver Transplantation: An Assessment of Serial MELD Measurements (2004) (111)
- Cytomegalovirus and its association with hepatic artery thrombosis after liver transplantation. (1998) (110)
- Primary Sclerosing Cholangitis (1984) (110)
- Manifestations of nonsuppurative cholangitis in chronic hepatobiliary diseases: morphologic spectrum, clinical correlations and terminology. (2008) (110)
- Recurrent and new hepatitis C virus infection after liver transplantation (1999) (109)
- Safety and efficacy of ambrisentan for the treatment of portopulmonary hypertension. (2011) (109)
- Elevation of plasma endothelin associated with systemic hypertension in humans following orthotopic liver transplantation. (1991) (106)
- Hepatocellular Carcinoma Is the Most Common Indication for Liver Transplantation and Placement on the Waitlist in the United States (2017) (106)
- Nephrotoxic effects of primary immunosuppression with FK-506 and cyclosporine regimens after liver transplantation. (1994) (105)
- Increased waiting time for liver transplantation results in higher mortality. (1997) (104)
- Diagnosis of chronic hepatitis C after liver transplantation by the detection of viral sequences with polymerase chain reaction (1992) (103)
- Histological evidence for recurrence of primary biliary cirrhosis after liver transplantation (1993) (103)
- Primary sclerosing cholangitis and celiac disease. A novel association. (1988) (102)
- The metabolic bone disease of primary sclerosing cholangitis (1991) (102)
- Immunohistochemical evidence of disease recurrence after liver transplantation for primary biliary cirrhosis. (1996) (101)
- INFLUENCE OF POSITIVE LYMPHOCYTE CROSSMATCH AND HLA MISMATCHING ON VANISHING BILE DUCT SYNDROME IN HUMAN LIVER ALLOGRAFTS (1988) (100)
- The Budd-Chiari syndrome. Medical and surgical management of 30 patients. (1985) (99)
- Dynamics of cytomegalovirus replication during preemptive therapy with oral ganciclovir. (2003) (98)
- Are patients with cirrhotic stage primary sclerosing cholangitis at risk for the development of hepatocellular cancer? (1997) (97)
- A prognostic model for the outcome of liver transplantation in patients with cholestatic liver disease (1997) (97)
- Cyclosporine withdrawal for nephrotoxicity in liver transplant recipients does not result in sustained improvement in kidney function and causes cellular and ductopenic rejection (1994) (96)
- Double‐dose accelerated hepatitis B vaccine in patients with end‐stage liver disease (2001) (96)
- The combination of ursodeoxycholic acid and methotrexate for patients with primary biliary cirrhosis: the results of a pilot study. (1995) (94)
- Azathioprine hepatotoxicity after liver transplantation (1991) (94)
- Evolving concepts in the diagnosis, pathogenesis, and treatment of chronic hepatic allograft rejection. (1999) (94)
- Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation (1997) (93)
- Pulmonary contraindications, indications and MELD exceptions for liver transplantation: a contemporary view and look forward. (2013) (93)
- Nonoperative dilatation of dominant strictures in primary sclerosing cholangitis. (1985) (92)
- Long‐term results and modeling to predict outcomes in recipients with HCV infection: Results of the NIDDK liver transplantation database (2004) (92)
- Complications of liver biopsy in liver transplant patients: Increased sepsis associated with choledochojejunostomy (1991) (92)
- Cholangiocarcinoma complicating primary sclerosing cholangitis: cholangiographic appearances. (1985) (91)
- Safety and efficacy of hepatitis A vaccination in liver transplantation recipients. (2001) (90)
- Natural history of vancomycin‐resistant enterococcal colonization in liver and kidney transplant recipients (2001) (89)
- Optimal timing of liver transplantation for primary biliary cirrhosis (1998) (89)
- Present state of immunosuppressive therapy in liver transplant recipients (2011) (89)
- Prophylaxis of cytomegalovirus infection in liver transplantation: a randomized trial comparing a combination of ganciclovir and acyclovir to acyclovir. NIDDK Liver Transplantation Database. (1997) (88)
- SPLENIC ARTERY ANEURYSMS IN LIVER TRANSPLANT PATIENTS (1988) (88)
- Improving Outcomes of Liver Retransplantation: An Analysis of Trends and the Impact of Hepatitis C Infection (2008) (85)
- Primary sclerosing cholangitis with normal serum alkaline phosphatase activity. (1988) (85)
- Long‐term outcome of human leukocyte antigen mismatching in liver transplantation: Results of the national institute of diabetes and digestive and kidney diseases liver transplantation database (2008) (84)
- Human herpesvirus 6 seronegativity before transplantation predicts the occurrence of fungal infection in liver transplant recipients. (1999) (84)
- Liver and intestine transplantation (2003) (84)
- Nonalcoholic Steatohepatitis is the Most Rapidly Growing Indication for Simultaneous Liver Kidney Transplantation in the United States (2016) (83)
- A prospective comparison of molecular diagnostic techniques for the early detection of cytomegalovirus in liver transplant recipients. (1995) (82)
- Late hypertension after liver transplantation: a comparison of cyclosporine and tacrolimus (FK 506). (1998) (81)
- EFFICACY OF GANCICLOVIR IN LIVER AND KIDNEY TRANSPLANT RECIPIENTS WITH SEVERE CYTOMEGALOVIRUS INFECTION (1988) (81)
- Recent advances in liver transplantation. (2003) (81)
- Acute liver failure associated with prolonged use of bromfenac leading to liver transplantation (1999) (79)
- Use of sirolimus in liver transplant recipients with renal insufficiency: A systematic review and meta‐analysis (2010) (79)
- Efficacy of tacrolimus as rescue therapy for chronic rejection in orthotopic liver transplantation: a report of the U.S. Multicenter Liver Study Group. (1997) (78)
- Serum type III procollagen peptide concentrations in severe chronic active hepatitis: Relationship to cirrhosis and disease activity (1987) (78)
- Prevention of Post‐transplant Cardiovascular Disease – Report and Recommendations of an Ad Hoc Group 1 (2002) (77)
- Intrahepatic cholangiectases and large‐duct obliteration in primary sclerosing cholangitis (1986) (77)
- Causes and outcome of seizures in liver transplant recipients (1996) (77)
- Abnormalities in tests of copper metabolism in primary sclerosing cholangitis. (1985) (77)
- Hepatic veno-occlusive disease associated with renal transplantation and azathioprine therapy. (1986) (76)
- The pathogenesis of hepatitis C virus is influenced by cytomegalovirus. (2002) (75)
- Model for end‐stage liver disease (MELD) exception guidelines (2006) (75)
- Hepatic allograft rejection: new developments in terminology, diagnosis, prevention, and treatment. (1993) (75)
- The economic impact of cytomegalovirus infection after liver transplantation. (2000) (74)
- De Novo Sirolimus and Reduced‐Dose Tacrolimus Versus Standard‐Dose Tacrolimus After Liver Transplantation: The 2000–2003 Phase II Prospective Randomized Trial (2014) (74)
- Primary sclerosing cholangitis: value of cholangiography in determining the prognosis. (1991) (73)
- Serum lipid and fat-soluble vitamin levels in primary sclerosing cholangitis. (1995) (73)
- Recurrent Primary Biliary Cirrhosis After Liver Transplantation (2010) (73)
- Analysis of factors that predict alcohol relapse following liver transplantation (2004) (72)
- Clinical and radiologic features of cerebral edema in fulminant hepatic failure. (1995) (72)
- Increased risk of chronic liver failure in adults with heterozygous alpha1-antitrypsin deficiency. (1998) (72)
- Role of steroid dose in hypertension early after liver transplantation with tacrolimus (FK506) and cyclosporine. (1996) (72)
- Liver transplantation for end-stage alcoholic liver disease: an assessment of outcomes. (1997) (72)
- Hepatic retransplantation in cholestatic liver disease: Impact of the interval to retransplantation on survival and resource utilization (1999) (71)
- Transplant Center Quality Assessment Using a Continuously Updatable, Risk‐Adjusted Technique (CUSUM) (2006) (71)
- Severe ductopenic rejection following liver transplantation: incidence, time of onset, risk factors, treatment, and outcome. (1992) (71)
- Increased risk of hepatocellular carcinoma in patients infected with hepatitis C genotype 1b. (1996) (70)
- Comparative allograft histology after liver transplantation for cryptogenic cirrhosis, alcohol, hepatitis C, and cholestatic liver diseases. (2000) (70)
- Patient selection in an era of donor liver shortage: current US policy (2005) (70)
- Detection of cytomegalovirus DNA in sera of liver transplant recipients (1994) (68)
- Pouchitis disease course after orthotopic liver transplantation in patients with primary sclerosing cholangitis and an ileal pouch-anal anastomosis. (1995) (67)
- Acute liver failure: results of a 5-year clinical protocol. (1995) (67)
- Liver transplantation for cryptogenic cirrhosis. (1997) (66)
- Organ-specific patterns of donor antigen-specific hyporeactivity and peripheral blood allogeneic microchimerism in lung, kidney, and liver transplant recipients. (1995) (66)
- Development of monoclonal gammopathy precedes the development of Epstein-Barr virus-induced posttransplant lymphoproliferative disorder. (1996) (66)
- Renal hemodynamics, urinary eicosanoids, and endothelin after liver transplantation. (1992) (65)
- Comparison of surgical treatment of ulcerative colitis associated with primary sclerosing cholangitis: ileal pouch-anal anastomosis versus Brooke ileostomy. (1996) (64)
- Evolving Frequency and Outcomes of Simultaneous Liver Kidney Transplants Based on Liver Disease Etiology (2014) (64)
- Significance of cytomegalovirus for long-term survival after orthotopic liver transplantation: a prospective derivation and validation cohort analysis. (1998) (62)
- Embolization of portosystemic shunts for treatment of medically refractory hepatic encephalopathy (2016) (62)
- Clinical significance of viral load in the diagnosis of cytomegalovirus disease after liver transplantation. (1998) (62)
- HEMOSTATIC EVALUATION OF PATIENTS UNDERGOING LIVER TRANSPLANTATION (1987) (62)
- Analysis of the reversibility of chronic liver allograft rejection implications for a staging schema. (1999) (62)
- Long-term comparison of tacrolimus versus cyclosporine in liver transplantation (1998) (61)
- Liver transplantation for primary sclerosing cholangitis: timing, outcome, impact of inflammatory bowel disease and recurrence of disease. (2001) (61)
- Current concepts. Primary sclerosing cholangitis. (1994) (61)
- Lack of association between cytomegalovirus infection, HLA matching and the vanishing bile duct syndrome after liver transplantation (1992) (60)
- Ulcerative colitis disease activity following treatment of associated primary sclerosing cholangitis with cyclosporin. (1993) (60)
- Nutritional support for liver transplantation: identifying caloric and protein requirements. (1994) (60)
- Cholangiocarcinoma complicating primary sclerosing cholangitis. (1991) (59)
- Resource Utilization in Liver Transplantation: Effects of Patient Characteristics and Clinical Practice (2000) (59)
- Complications and risk factors after ileal pouch-anal anastomosis for ulcerative colitis associated with primary sclerosing cholangitis. (1993) (58)
- Orthotopic liver transplantation for hereditary fibrinogen amyloidosis. (2003) (57)
- The impact of immunosuppressive regimens on the cost of liver transplantation--results from the U.S. FK506 multicenter trial. (1995) (57)
- Enhanced autoreactivity of T‐lymphocytes in primary sclerosing cholangitis (1987) (57)
- Clinical and statistical analyses of new and evolving therapies for primary biliary cirrhosis (1988) (56)
- Treatment of recurrent hepatocellular carcinoma after liver transplantation (2011) (55)
- Outcome of liver transplantation for familial amyloidotic polyneuropathy (2003) (55)
- Relevance and risk factors of enterococcal bacteremia following liver transplantation. (1996) (54)
- Early Detection of Hepatitis C Allograft Reinfection after Orthotopic Liver Transplantation: A Molecular and Histologic Study (2000) (54)
- Anti‐tumour necrosis factor treatment of inflammatory bowel disease in liver transplant recipients (2012) (53)
- Incidence of cytomegalovirus infection and its relationship to donor-recipient serologic status in liver transplantation. (1987) (53)
- Differential allograft gene expression in acute cellular rejection and recurrence of hepatitis C after liver transplantation (2002) (52)
- Outcomes of Liver Transplantation Alone After Listing for Simultaneous Kidney: Comparison to Simultaneous Liver Kidney Transplantation (2015) (52)
- The syndrome of primary sclerosing cholangitis. (1990) (52)
- Renal sodium handling with cyclosporin A and FK506 after orthotopic liver transplantation. (1995) (52)
- Bone loss after orthotopic liver transplantation: FK 506 versus cyclosporine. (1996) (51)
- Early diagnosis of cytomegalovirus hepatitis in liver transplant recipients: Role of immunostaining, dna hybridization and culture of hepatic tissue (1990) (50)
- Pirfenidone in the Treatment of Primary Sclerosing Cholangitis (2004) (50)
- Carolina rinse solution decreases liver injury during clinical liver transplantation. (1993) (49)
- Diagnosis and treatment of primary sclerosing cholangitis. (1985) (49)
- Celiac disease autoantibodies in severe autoimmune liver disease and the effect of liver transplantation (2008) (49)
- Adaptation of the mayo primary biliary cirrhosis natural history model for application in liver transplant candidates (2000) (49)
- Advances in the diagnosis, treatment, and prevention of cytomegalovirus infections after liver transplantation. (1993) (48)
- Use of Prograf (FK 506) as rescue therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group. (1993) (48)
- MELD / PELD and the allocation of deceased donor livers for status 1 recipients with acute fulminant hepatic failure, primary nonfunction, hepatic artery thrombosis, and acute Wilson's disease (2004) (48)
- Intracerebral hemorrhage in liver transplant recipients. (1995) (48)
- Reduced Priority MELD Score for Hepatocellular Carcinoma Does Not Adversely Impact Candidate Survival Awaiting Liver Transplantation (2006) (47)
- Cyclosporin A-induced reversible cortical blindness. (1988) (46)
- Noninvasive diagnosis of acute cellular rejection in liver transplant recipients: A proteomic signature validated by enzyme‐linked immunosorbent assay (2011) (46)
- Loss of nocturnal blood pressure fall after liver transplantation during immunosuppressive therapy. (1995) (46)
- Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: predicting outcomes with natural history models. (1998) (46)
- Phaeohyphomycosis due to Scopulariopsis brumptii in a liver transplant recipient. (1994) (45)
- Neuromuscular complications associated with liver transplantation (1996) (44)
- CD40L (CD154) expression in human liver allografts during chronic ductopenic rejection. (1999) (44)
- Evidence‐based evolution of the MELD/PELD liver allocation policy (2005) (44)
- Non-A, non-B fulminant hepatitis is also non-E and non-C. (1994) (43)
- Clinical outcome of ischemic-type biliary complications after liver transplantation. (1993) (43)
- Hemodynamic and metabolic changes in hepatic transplantation. (1989) (43)
- Subclinical reactivation of hepatitis B virus in liver transplant recipients with past exposure (2003) (42)
- Advances in primary sclerosing cholangitis. (1990) (42)
- A controlled analysis of the transjugular intrahepatic portosystemic shunt in liver transplant recipients. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Liver Transplantation Database. (1997) (41)
- Acute confusional state following liver transplantation for alcoholic liver disease (2002) (41)
- A prospective study of pulmonary function and gas exchange following liver transplantation. (1992) (41)
- Papillary bile duct dysplasia in primary sclerosing cholangitis. (1992) (41)
- Role of endoscopic retrograde cholangiopancreatography after orthotopic liver transplantation. (1992) (41)
- Survival after liver transplantation in diabetics. (1991) (40)
- Evidence that the liver does not always protect the kidney from hyperacute rejection in combined liver-kidney transplantation across a positive lymphocyte crossmatch. (1990) (40)
- The use of sirolimus should be restricted in liver transplantation. (2012) (40)
- Epstein‐Barr virus and persistent graft dysfunction after liver transplantation (1991) (39)
- Primary sclerosing cholangitis: a progressive disease? (1991) (39)
- Neoral compared to Sandimmune is associated with a decrease in histologic severity of rejection in patients undergoing primary liver transplantation. (1997) (39)
- Hepatitis C genotypes in liver transplant recipients: distribution and 1-year follow-up. (1995) (39)
- A comparative study of patients undergoing liver transplantation for primary sclerosing cholangitis and primary biliary cirrhosis. (1991) (39)
- Primary sclerosing cholangitis. (1984) (38)
- Beyond 1 year after liver transplantation. (1989) (37)
- Natural history and management of hepatitis C infection after liver transplantation. (2004) (37)
- Evaluation of preoperative hematology-coagulation screening in liver transplantation. (1989) (37)
- Systemic and Renal Effects of Nifedipine in Cyclosporine‐Associated Hypertension (1994) (37)
- Prognostic significance and risk factors of untreated cytomegalovirus viremia in liver transplant recipients. (1996) (36)
- Early cellular rejection after orthotopic liver transplantation correlates with low concentrations of FK506 in hepatic tissue (1995) (35)
- Late hepatic allograft dysfunction (2001) (35)
- Preliminary results: Outcome of liver transplantation for hepatitis B virus varies by hepatitis B virus genotype (2002) (35)
- Hepatitis A antibodies in liver transplant recipients: Evidence for loss of immunity posttransplantation (2000) (35)
- Hepatic allograft cyclosporine concentration is independent of the route of cyclosporine administration and correlates with the occurrence of early cellular rejection (1992) (35)
- Ultrasound-assisted percutaneous liver biopsy performed by a physician assistant. (2002) (34)
- METHODS TO ESTIMATE AND ANALYZE MEDICAL CARE RESOURCE USE (1999) (34)
- Comparing nephrotoxicity of FK 506 and cyclosporine regimens after liver transplantation: preliminary results from US Multicenter trial. U.S. Multicenter Liver Study Group. (1995) (33)
- Severe ductopenic rejection with features of vanishing bile duct syndrome: clinical, biochemical, and histologic evidence for spontaneous resolution. (1991) (33)
- Enzyme inhibitory autoantibodies to pyruvate dehydrogenase complex in primary biliary cirrhosis: Applications of a semiautomated assay (1994) (33)
- Central pontine myelinolysis with stupor alone after orthotopic liver transplantation. (1996) (33)
- The nitric oxide donor sodium nitroprusside is protective in ischemia/reperfusion injury of the pancreas. (1998) (32)
- Primary biliary cirrhosis has high wait‐list mortality among patients listed for liver transplantation (2017) (32)
- Epidemiology and natural history of hepatitis C infections in liver transplant recipients. (1995) (31)
- Mycophenolate Mofetil Use Is Associated with Decreased Risk of Late Acute Rejection in Adult Liver Transplant Recipients (2006) (30)
- Human liver and conjugation of catecholamines. (1987) (30)
- Excellent long-term survival following liver transplantation in primary sclerosing cholangitis patients (1998) (30)
- Frequency, clinical presentation, and outcomes of drug‐induced liver injury after liver transplantation (2012) (30)
- Application of the Mayo primary biliary cirrhosis survival model to Mayo liver transplant patients. (1989) (30)
- Ultrasound-assisted percutaneous liver biopsy performed by a physician assistant (2002) (30)
- Long-term outcome after liver transplantation. (1989) (29)
- Predicting clinical and economic outcomes after liver transplantation using the mayo primary sclerosing cholangitis model and child‐pugh score (2000) (29)
- Congestive gastropathy and other upper endoscopic findings in 81 consecutive patients undergoing orthotopic liver transplantation. (1990) (29)
- Influence of human fulminant hepatic failure sera on endogenous retroviral expression in pig hepatocytes (2000) (28)
- Combination immunosuppression with azathioprine reduces the incidence of ductopenic rejection and vanishing bile duct syndrome after liver transplantation. (1991) (28)
- Etiology and natural history of primary sclerosing cholangitis. (1999) (28)
- Precore and contiguous regions of hepatitis B virus in liver transplantation for end-stage hepatitis B. (1994) (28)
- A positive lymphocyte cross-match and major histocompatibility complex mismatching do not predict early rejection of liver transplants in patients treated with cyclosporine. (1987) (27)
- Risk Factors and Outcomes of De Novo Cancers (Excluding Nonmelanoma Skin Cancer) After Liver Transplantation for Primary Sclerosing Cholangitis (2017) (27)
- Late recurrence and rapid evolution of severe hepatopulmonary syndrome after liver transplantation. (1999) (26)
- Treatment of early cellular rejection following liver transplantation with intravenous methylprednisolone. The effect of dose on response. (1994) (26)
- Is hepatic histology the true gold standard in diagnosing acute hepatic allograft rejection? (1996) (25)
- Liver Transplantation and Hepatitis B (1997) (25)
- Oral cyclosporine decreases severity of neurotoxicity in liver transplant recipients (1999) (25)
- Simultaneous liver kidney transplantation (2019) (25)
- Beyond 2000 (2001) (25)
- Solid organ transplantation: Results and implications of acyclovir use in liver transplants (1993) (24)
- Model for end‐stage liver disease (MELD) exception for bacterial cholangitis (2006) (24)
- Advances in diagnosis, prevention, and management of hepatic allograft rejection. (1994) (24)
- Factors Influencing Surveillance for Hepatocellular Carcinoma in Patients with Liver Cirrhosis (2016) (24)
- Liver transplantation for jejunoileal bypass-associated cirrhosis: allograft histology in the setting of an intact bypassed limb. (1997) (24)
- Addition of MMF to Dual Immunosuppression Does Not Increase the Risk of Malignant Short‐Term Death After Liver Transplantation (2005) (24)
- The impact of cyclosporine dose and level on acute rejection and patient and graft survival in liver transplant recipients. (1998) (24)
- Clinical and pathological features of graft-versus-host disease after liver transplantation: A case report and review of the literature (1993) (24)
- Recent advances in the management of primary sclerosing cholangitis. (1987) (23)
- Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group. (1993) (23)
- Impact of Depressive Symptoms and Their Treatment on Completing Antiviral Treatment in Patients With Chronic Hepatitis C (2010) (23)
- Anesthesia approach to hepatic transplantation. (1989) (23)
- Persistent bile leak after liver transplantation: biloma drainage and endoscopic retrograde cholangiopancreatographic sphincterotomy. (1991) (23)
- Blood bank support of a liver transplantation program. (1989) (23)
- Serial determinations of the amino-terminal peptide of type III procollagen in severe chronic active hepatitis. (1987) (23)
- IMMUNOHISTOLOGIC LABELING AS AN INDICATOR OF LIVER ALLOGRAFT REJECTION (1987) (23)
- Impaired initial function in liver grafts from donors > 50 years of age. (1993) (23)
- Primary nonfunction of the liver graft: when should we retransplant? (1991) (22)
- Lymphocyte subsets in primary sclerosing cholangitis (1987) (22)
- Impact of fibrosis progression on clinical outcome in patients treated for post‐ transplant hepatitis C recurrence (2015) (22)
- Not All Cellular Rejections Are the Same: Differences in Early and Late Hepatic Allograft Rejection (2019) (21)
- Hypertension after liver transplantation: a predictive role for pretreatment hemodynamics and effects of isradipine on the systemic and renal circulations. (2000) (21)
- Liver transplantation for primary sclerosing cholangitis: impact of risk factors on outcome. (1996) (21)
- Enhanced liver calpain protease activity is a risk factor for dysfunction of human liver allografts. (1997) (21)
- Concentrations of 3,4‐Dihydroxyphenylalanine and Catecholamines and Metabolites in Brain in an Anhepatic Model of Hepatic Encephalopathy (1995) (21)
- Cyclosporine A-induced side effects related to a low total serum cholesterol level: an indication for a free cyclosporine A assay? (1988) (20)
- Orthotopic liver transplantation for preoperative early-stage hepatocellular carcinoma. (1994) (20)
- Hepatitis C virus infection and lymphoproliferative disorders after liver transplantation (2000) (19)
- Endotheliitis in hepatic allografts. (1989) (19)
- Intragraft localization of activated nuclear factor κB in recurrent hepatitis C virus disease following liver transplantation (2000) (19)
- 113 A phase 2 dose-escalation study of albuferon combined with ribavirin in non-responders to prior interferon-based therapy for chronic hepatitis C infection (2006) (19)
- Use of FK 506 for the prevention of recurrent allograft rejection after successful conversion from cyclosporine for refractory rejection. US Multicenter FK 506 Liver Study Group. (1993) (19)
- Acquired (non‐Wilsonian) hepatocerebral degeneration: Complex management decisions (2003) (18)
- The pathogenesis of hepatitis c virus (HCV) is strongly influenced by cytomegalovirus (CMV) (2002) (18)
- Progression of primary biliary cirrhosis with ursodeoxycholic acid therapy. (1992) (18)
- Curricular guidelines for training in transplant hepatology (2002) (18)
- Acute fulminant hepatic failure. (1991) (17)
- Hepatitis B virus replication patterns after orthotopic liver transplantation: de novo versus recurrent infection. (1993) (17)
- Selective bowel decontamination to prevent gram-negative bacterial and fungal infection following orthotopic liver transplantation. (1987) (17)
- Advanced liver failure predisposes to cyclosporine-induced central nervous system symptoms after liver transplantation. (1989) (16)
- The autologous mixed lymphocyte reaction in primary biliary cirrhosis: Analysis of activation and blastogenesis of autoreactive T lymphocytes (1988) (15)
- Is primary sclerosing cholangitis a progressive disease or not? (1988) (15)
- MELD: the end of Child-Pugh classification? (2002) (14)
- Liver transplantation for hepatitis B: the con aspect. (1995) (14)
- Granulomatous destruction of bile ducts after liver transplantation: Primary biliary cirrhosis recurrence or hepatitis C virus infection? (1995) (14)
- Erratum: Risk factors for cytomegalovirus and severe bacterial infections following liver transplantation: A prospective multivariate time-dependent analysis (Journal of Hepatology (1993) 18 (185-195)) (1993) (14)
- Mayo end stage liver disease model (MELD) score predicts liver transpiant walting list mortality: Implications for liver allocation policy (2001) (14)
- Hepatic allograft rejection is associated with increased levels of soluble intercellular adhesion molecule-1. (1995) (13)
- Focal Dilatation of Intrahepatic Bile Ducts (Caroli's Disease), Cholangiocarcinoma, and Sclerosis of Extrahepatic Bile Ducts: A Case Report (1982) (13)
- Other clinical studyEarly cellular rejection after orthotopic liver transplantation correlates with low concentrations of FK506 in hepatic tissue (1995) (13)
- The incidence of gram-negative bacterial and fungal infections in liver transplant patients treated with selective decontamination (2005) (13)
- Recurrence of ductopenic rejection in liver allografts after retransplantation for vanishing bile duct syndrome. (1991) (13)
- Liver allograft iron accumulation in patients with and without pretransplantation hepatic hemosiderosis (2002) (12)
- Diagnosis of cytomegalovirus hepatitis by histopathology and in situ hybridization in liver transplantation. (1991) (12)
- Clinical evaluation of a new recombinant antigen-based cytomegalovirus immunoglobulin M immunoassay in liver transplant recipients. (2001) (12)
- Applications of duplex ultrasonography in the liver transplant patient. (1990) (12)
- Progression of primary biliary cirrhosis with ursodeoxycholic acid therapy. (1994) (12)
- Factor XII Deficiency Acquired by Orthotopic Liver Transplantation: Case Report and Review of the Literature (2006) (12)
- Results of treatment in hepatic allograft rejection depend on the immunohistologic pattern of the portal T lymphocyte infiltrate. (1988) (12)
- Hepatitis G virus infection before and after liver transplantation. Liver Transplantation Database. (1997) (12)
- Conversion from standard cyclosporine to low-dose cyclosporine and azathioprine therapy as treatment for cyclosporine-related complications in liver transplant patients. (1987) (12)
- Immunohistologic pattern of the portal T-lymphocyte infiltration in hepatic allograft rejection. (1989) (12)
- Original aricleInfluence of human fulminant hepatic failure sera on endogenous retroviral expression in pig hepatocytes (2000) (11)
- Selective bowel decontamination for infection prophylaxis in liver transplantation patients. (1991) (11)
- Hepatitis G virus infection in patients transplanted for cryptogenic cirrhosis: red flag or red herring? (1998) (11)
- UW solution improves duration and quality of clinical liver preservation. (1990) (11)
- D-penicillamine improves survival and retards histologic progression in primary biliary cirrhosis (1982) (10)
- Management of ascites in patients with cirrhosis. What to do when diuretics fail. (1992) (10)
- Prediction of liver transplant outcome using the MELD scale (2001) (10)
- Soluble T lymphocyte markers in the diagnosis of cellular rejection and cytomegalovirus hepatitis in liver transplant recipients. (1994) (9)
- Hepatitis C antibodies in patients with chronic hepatitis of unknown etiology after orthotopic liver transplantation. (1991) (9)
- Liver and Kidney Recipient Selection of HCV-Viremic Donors - Meeting Consensus Report from the 2019 Controversies in Transplantation. (2020) (9)
- Immunomodulating therapy in liver transplantation: principles and practice. (2012) (9)
- The role of portosystemic shunts for variceal bleeding in the liver transplantation era. (1994) (9)
- Fulminant hepatitis B virus: recurrence after liver transplantation in two patients also infected with hepatitis delta virus. (1997) (9)
- Early cellular rejection treated with high-dose intravenous corticosteroid therapy is associated with a decrease in the incidence of steroid-resistant rejection and graft failure from rejection. (1993) (8)
- Etiology and incidence of unconjugated hyperbilirubinemia after orthotopic liver transplantation. (1994) (8)
- Do cold agglutinins have any impact on the outcome of liver transplantation? (1996) (8)
- Acute Liver Failure Prognostic Scores: Is Good Enough Good Enough? (2016) (8)
- Current therapies and clinical controversies in the management of primary sclerosing cholangitis (2000) (8)
- Charcoal hemoperfusion in the treatment of medically refractory pruritus in cholestatic liver disease (2017) (8)
- Should we change the priority for liver allocation for patients with the highest MELD score? (2012) (7)
- Is primary sclerosing cholangitis a bad disease? (1987) (7)
- Does propranolol precipitate hepatic encephalopathy? (1986) (7)
- Pharmacokinetics of D-penicillamine in normals and primary biliary cirrhosis (PBC) (1979) (7)
- PREVALENCE , IMPACT , AND ETIOLOGY OF RENAL INSUFFICIENCY IN LIVER TRANSPLANTATION Scope of the Problem and Impact on Outcomes (2009) (7)
- The model for end-stage liver disease (MELD) score predicts survival in patients with spontaneous bacterial peritontis, and with ascites (2001) (6)
- Subspecialty clinics : Pulmonary and critical care medicine : Hepatopulmonary syndrom with progressive hypoxemia as an indication for liver transplantation : Case reports and literature review (1997) (6)
- Pharmacokinetics of cyclosporine in patients with primary biliary cirrhosis. (1988) (6)
- The clinical significance of simultaneous infection with hepatitis G virus in patients with chronic hepatitis C (1999) (6)
- Predictors of primary nonfunction: is donor liver fat content important? (1993) (6)
- Evolving trends in liver transplantation: listing and liver donor allocation. (2014) (6)
- Blood product transfusion therapy after liver transplantation: comparison of the thromboelastogram and conventional coagulation studies. (1993) (6)
- The clinical significance of simultaneous infection with hepatitis G virus in patients with chronic hepatitis C. (1999) (6)
- Antibody response to cytomegalovirus (CMV) polypeptides in liver transplant recipients with CMV hepatitis. (1992) (6)
- Long-term comparison of tacrolimus versus cyclosporine in liver transplantation. The US FK Study Group. (1998) (6)
- A comparison of azathioprine and cyclosporine in liver transplantation: a study of two personal series. (1987) (6)
- 456 Safety, pharmacokinetics and pharmacodynamic results of higher doses of albuferon in a phase single and double dose-escalation study in treatment experienced subjects with chronic hepatitis C (2004) (5)
- Increasing peripheral T lymphocyte counts predict rejection in human orthotopic liver allografts (1988) (5)
- Fulminant hepatitis B virus: Recurrence after liver transplantation in two patients also infected with hepatitis delta virus (1997) (5)
- Immunohistochemical evidence of disease recurrence after liver transplantation for primary biliary cirrhosis (1996) (5)
- Immunohistologic labeling of infiltrating T lymphocytes in hepatic allografts: a rejection indicator. (1987) (5)
- Twelve years of liver transplantation at the Mayo Clinic. (1997) (5)
- Reverse transcriptase-polymerase chain reaction fails to detect peripheral-blood hepatitis C RNA in formalin-fixed liver tissue. (1998) (4)
- Effect of minimal listing criteria on waiting list registration for liver transplantation: a process-outcome analysis. (2003) (4)
- Cytomegalovirus infection after liver transplantation: Incidence, timing, and predictors of disease severity (1991) (4)
- 435 Does the model for end-stage liver disease (MELD) predict post liver transplant graft survival? (2003) (4)
- Association of α 1 Antitrypsin Phenotype and Development of Advanced Liver Disease and Pulmonary Complications Before and After Liver Transplantation. (2020) (4)
- Kupffer cell expression of CD40L (CD154) in human chronic liver allograft rejection. (1999) (4)
- Hepatocellular carcinoma in patients infected with different hepatitis C genotypes (1995) (4)
- Lack of evidence for hepatitis B virus (HBV) infection in fulminant non-A, non-B hepatitis (1994) (4)
- The MELD/PELD liver allocation policy is associated with a reduction in waiting list mortality while maintaining excellent posttransplant patient and graft survival (2003) (4)
- Model for end-stage liver disease (MELD) predicts survival in patients with variceal bleeding (2003) (3)
- Selective activation of suppressor T lymphocytes by cyclosporine in the autologous mixed lymphocyte reaction (1986) (3)
- Moving toward evidence‐based liver allocation in patients with primary sclerosing cholangitis (2013) (3)
- Prolonged anuria complicating primary sclerosing cholangitis: successful outcome following orthotopic liver transplantation. (1998) (3)
- Granulocyte accumulation in the transplanted liver does not correlate with clinical and histologic evidence of dysfunction. (1996) (3)
- Antemortem diagnosis and short-term survival of a patient with Wilson's disease presenting as fulminant hepatic failure (1984) (3)
- Familial occurrence of liver disease and inflammatory bowel disease in primary sclerosing cholangitis (1987) (3)
- EFFICACY OF MYCOPHENOLATE MOFETIL (MMF) IN LIVER TRANSPLANT RECIPIENTS: RESULTS OF A RANDOMIZED DOUBLE BLIND COMPARATIVE STUDY WITH AN ANALYSIS OF THE IMPACT OF HEPATITIS C.: Abstract# 27 (2000) (3)
- INSULIN RESISTANCE, SERUM ADIPOKINES AND THE RISK OF FIBROSIS PROGRESSION IN PATIENTS TRANSPLANTED FOR HEPATITIS C: A PROSPECTIVE COHORT STUDY: 184 (2008) (3)
- Is continued enthusiasm for ursodeoxycholic acid therapy for the treatment of primary biliary cirrhosis warranted? (1992) (3)
- Primary Sclerosing Cholangitis and Celiac Disease (2020) (2)
- Long-term management of liver transplant recipients (1993) (2)
- S1801 A Multi-Centered Prospective Analysis of Long-Term Causes of Mortality Post Liver Transplantation: Results of the Niddk Database (2008) (2)
- Unique hepatic gene expression in NASH-candidates for a genetic basis of disease (2001) (2)
- Risk factors following for cytomegalovirus and severe bacterial infections liver transplantation: a prospective multivariate time-dependent analysis (1993) (2)
- An open-label study of the safety and tolerability of converting stable liver transplant recipients to neoral. (1998) (2)
- Is there disease progression in patients who are hepatitis C virus antibody–positive and hepatitis C virus RNA–seronegative? (2008) (2)
- Superior Vena Cava Reconstruction Using An Iliocaval Allograft (1996) (2)
- The spectrum of nonalcoholic fatty liver disease with normal liver enzymes (2003) (2)
- Human leukocyte antigen DR markers as predictors of progression to liver transplantation in patients with chronic hepatitis C (2000) (2)
- Advances in therapy for primary sclerosing cholangitis : Primary sclerosing cholangitis : recent developments (1992) (2)
- Somatic muscle catabolism is accelerated after liver transplantation. (1993) (2)
- Effects of cyclosporine on lymphocyte blastogenesis: Analysis of dose-response relationships and interindividual variability in healthy adults (1986) (2)
- H14 - Effect of diuretics on blood pressure and cyclosporine nephrotoxicity after liver transplantation (TX) (1995) (2)
- Heavy Alcohol Use Among Deceased Donors Does Not Impact Recipient Outcomes After Liver Transplantation (2018) (2)
- 131 Pulmonary vascular complications of liver disease: survival analysis of 140 patients evaluated at mayo clinic (2003) (2)
- Primary Sclerosing Cholangitis and Other Cholangiopathies (2009) (1)
- Exploring the Spectrum of Pathology and Treatment in Portopulmonary Hypertension: Four Experts Address the Toughest Questions (2004) (1)
- Effect of cyclosporine dosing on creatinine levels in hepatic transplant recipients. (1994) (1)
- PREDICTING OUTCOMES OF LIVER TRANSPLANTATION IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS (PSC) USING THE MAYO PSC MODEL AND THE CHILD-PUGH SCORE (1999) (1)
- Competition and selection among different HCV strains (2001) (1)
- 183 RECURRENCE OF PRIMARY SCLEROSING CHOLANGITIS AFTER LIVER TRANSPLANTATION (2013) (1)
- Rate, Risk Factors, and Outcomes of Cancer After Liver Transplantation for Primary Sclerosing Cholangitis: 2176 (2015) (1)
- Progression of primary biliary cirrhosis on ursodeoxycholic acid. (1994) (1)
- Cerebral Manifestations of Whipple's Disease: Dr. Wiesner replies (1988) (1)
- Prophylaxis and Treatment of Cytomegalovirus Infection after Solid Organ Transplantation (2012) (1)
- 90th Annual Convention Poster Presentations and Abstracts (1991) (1)
- Su1000 Patients With Primary Biliary Cirrhosis Have the Highest Wait-List Mortality (2015) (1)
- Apply sound scientific methodology to the evaluation of new medical treatments (2011) (1)
- 842 Contemporary Predictors of Simultaneous Liver Kidney Transplant (SLK) and Post-Transplant Patient and Liver Graft Survival (2012) (1)
- Chapter 20 – Primary Sclerosing Cholangitis (2006) (1)
- Liver Transplantation and Blood Usage (1991) (1)
- The Role of Cell-Based Bioartificial Liver Therapy in the Treatment of Fulminant Hepatic Failure (2002) (1)
- 430 Results of liver transplantation for hepatocellular cancer (HCC) under the MELD/PELD system for liver allocation (2003) (1)
- Immunosuppression: The Global Picture (2011) (1)
- Systemic arterial hypertension in the immediate postoperative period of liver transplantation: Role of endothelin? (1990) (1)
- From the editorsThe changing of the guard: A new editorial team (2000) (1)
- Getting ready for the second half (2002) (1)
- WARM ISCHEMIA TIME IS AN IMPORTANT FACTOR FOR THE DEVELOPMENT OF NON-ANASTOMOTIC BILIARY STRICTURES. (1999) (0)
- Benefit of living donor liver transplantation: Who and when? (2011) (0)
- HIGHER PRETRANSPLANT HCV RNA LEVELS ASSOCIATED WITH POOR PATIENT AND GRAFT SURVIVAL (1998) (0)
- 127Recurrence of primary biliary cirrhosis after liver transplantation: An update on incidence (2000) (0)
- Su1302 Predictors of Combined Liver and Kidney Transplantation and Post-Transplant Liver Graft, Kidney Graft, and Patient Survival: Comparison to Patients Receiving Listed for Kidney but Receiving Liver Alone (2013) (0)
- Information of APPLE 2017 (2017) (0)
- Primary sclerosing cholangitis: Advances in diagnosis, etiopathogenesis and treatment (1999) (0)
- Human leukocyte antigen DR markers as predictors of progression to liver transplantation in patients with chronic hepatitis C. (2000) (0)
- Predictors of Combined Liver and Kidney Transplantation and Post-Transplant Liver Graft, Kidney Graft, and Patient Survival: Comparison to Patients Listed for Kidney but Receiving Liver Alone. (2013) (0)
- Low tacrolimus levels during the first week after liver transplantation are associated with an increased incidence of early acute rejection. (2001) (0)
- DO DIURETICS IMPAIR RENAL FUNCTION AFTER TRANSPLANTATION?: Abstract# 791 Poster Board #‐Session: P48‐III (2000) (0)
- THE POTENTIAL ROLE OF CLASS II ANTIGENS IN RECURRENCE OF PSC FOLLOWING LIVER TRANSPLANTATION. (1999) (0)
- TISSUE HCV RNA LEVELS FOLLOWING LIVER TRANSPLANTATION FOR HEPATITIS C ‐ TIME COURSE AND IMPACT OF CYLCLOSPORINE VS. TACROLIMUS.: Abstract# 221 Poster Board #‐Session: P68‐I (2000) (0)
- Mayo Clinic office visit. Organ donation. An interview with Russell Wiesner, M.D. (2006) (0)
- P-305: The spectrum of large and small vessel changes in a model of developing human hypertension (HTN) (2003) (0)
- Approaching our final year (2004) (0)
- Su1004 Impact of Decompensation on Wait-List Mortality Among Patients With Listing MELD Score Below 15 (2015) (0)
- CONCOMITANT ACTIVATION OF THE TRANSCRIPTION FACTOR NF-κB & NF-κB-RESPONSIVE INFLAMMATORY GENES IN HUMAN LIVER ALLOGRAFTS DURING CHRONIC DUCTOPENIC REJECTION (1999) (0)
- Immunology of liver transplantation (1994) (0)
- The combination of ursodeoxycholic acid and methotrexate for patients with primary biliary cirrhosis: The results of a pilot study (1995) (0)
- Medical Aspects of Liver Transplantation (2002) (0)
- 107 INSULIN RESISTANCE, SERUM ADIPOKINES AND THE RISK OF FIBROSIS PROGRESSION IN PATIENTS TRANSPLANTED FOR HEPATITIS C: A PROSPECTIVE COHORT STUDY (2008) (0)
- Prevalence and clinical significance of HFE gene mutations in patients undergoing evaluation for liver transplantation (2003) (0)
- Safety and efficacy of thymoglobulin for steroid resistant acute cellular rejection following live rtransplantation (2007) (0)
- Outcomes In the Pre-Rituximab and Post-Rituximab Eras In Post-Transplantation Lymphoproliferative Disorders (PTLD) In Adult Solid Organ Transplant Recipients (2010) (0)
- Posttransplant lymphoproliferative disease following orthotopic liver transplantation (1995) (0)
- Progression of Primary Biliary Ursodeoxycholic Acid Therapy (1992) (0)
- Evolving Frequency with Graft and Patient Survival of Liver Transplantation Based on Etiology of Liver Disease Presidential Poster: 465 (2012) (0)
- LIVER ALLOGRAFT NF‐KB ACTIVATION CORRELATES WITH SEVERITY OF HISTOLOGICAL DISEASE AND FIBROSIS IN HEPATITIS C VIRUS RECURRENCE.: Abstract# 599 (2000) (0)
- The changing of the guard: A new editorial team (2000) (0)
- L1: Cancer after liver transplantation (TX): Excess risk associated with calcium channel blocker administration? (1997) (0)
- Incidence, Severity, and Outcome of Recurrent Hepatitis C is Similar in Patients Immunosuppressed with Neoral and Sandimmune (1998) (0)
- Impact factor 2002 (2002) (0)
- Anti-Tumor Necrosis Factor Therapy for Inflammatory Bowel Disease Management in Liver Transplant Recipients: 1223 (2010) (0)
- Is the prevalence of the HFE C282Y gene mutation and alpha 1 antitrypsin Z allele increased in patients with end-stage liver disease related to hepatitis C and other etiologies? (2003) (0)
- Chapter 15 – Primary sclerosing cholangitis (2004) (0)
- Reply: (2005) (0)
- CARDIOVASCULAR RISK FACTORS AFTER LIVER TRANSPLANTATION (LT): COMPARISON OF MICROEMULSION CYCLOSPORINE (NEORAL), CONVENTIONAL CYCLOSPORINE (CSA), AND TACROLIMUS. (1999) (0)
- ADAPTATION OF THE MAYO PRIMARY BILIARY CIRRHOSIS MODEL FOR MINIMUM LISTING CRITERIA FOR LIVER TRANSPLANT CANDIDATES (1998) (0)
- [Complications and risk factors of ileo-anal anastomosis with reservoir for ulcero-hemorrhagic rectocolitis associated with primary sclerosing cholangitis]. (1993) (0)
- CLINICAL AND ECONOMIC IMPLICATIONS OF USING ANTI-HBc-POSITIVE DONORS FOR LIVER TRANSPLANTATION (1998) (0)
- Erratum: SRTR report on the state of transplantation:. Liver and intestine transplantation. American Journal of Transplantation (2003) 3 (78-90)) (2003) (0)
- 169Activation of the transcription factor NF-κB & induction of NF-κB-responsive inflammatory genes in human liver allografts during chronic ductopenic rejection (2000) (0)
- vidence-Based Incorporation of Serum Sodium Concentration nto MELD (2006) (0)
- Reply (2001) (0)
- The pharmacokinetics of D-penicillamine in health and primary biliary cirrhosis (PBC) (1980) (0)
- Rate, Risk Factors, and Outcomes of Recurrence of Primary Sclerosing Cholangitis After Liver Transplantation: 2168 (2015) (0)
- LOWER QUALITY OF LIFE IN LIVER TRANSPLANT RECIPIENTS WITH HEPATITIS C.: Abstract# 398 Poster Board #‐Session: P38‐II (2000) (0)
- Good news for our journal Liver Transplantation (2000) (0)
- INCREASED MORTALITY FOLLOWING ACUTE CELLULAR REJECTION IN HCV-INFECTED LIVER TRANSPLANT RECIPIENTS (1999) (0)
- Clinical epidemiology and assessment of disease severity among patients recently referred for evaluation at a major liver transplantation center (2000) (0)
- REMOTE CONTROL: OUTCOMES UTILIZING TELEMEDICINE FOR OFF‐SITE PRE‐TRANSPLANT EVALUATION AND POST‐TRANSPLANT LONG‐TERM CARE.: Abstract# 989 (2000) (0)
- Tu1013 De novo Non-Skin Malignancy Risk After Liver Transplantation for Primary Sclerosing Cholangitis (2013) (0)
- ACTIVATION OF NF-κB IN HEPATITIS C VIRUS INFECTED LIVER ALLOGRAFTS (1999) (0)
- 197NF-κB activation in liver allografts correlates with severity of histological disease & fibrosis in recurrent hepatitis C virus disease (2000) (0)
- Hepatic histology predicts outcome of OKT3 rescue therapy in liver transplantation (1990) (0)
- Incidence, Diagnosis, Prevention, and Management of Acute Kidney Injury in Patients with Cirrhosis (2009) (0)
- Recurrence of Primary Biliary Cirrhosis Following Liver Transplantation (2016) (0)
- Sclerosing cholangitis. (1997) (0)
- CURRENT APPROACH TO THE UTILIZATION OF LIVER DONORS POSITIVE FOR EITHER ANTI-HBC OR ANTI-HCV IN THE UNITED STATES. (1999) (0)
- OUTCOME OF LIVER TRANSPLANTATION USING PEDIATRIC DONORLIVERS FOR ADULT RECIPIENTS. (1999) (0)
- EARLY IDENTIFICATION OF RECIPIENTS WITH MORE SEVERE HISTOLOGICAL RECURRENCE OF HCV FOLLOWING LIVER TRANSPLANTATION.: Abstract# 593 (2000) (0)
- History of Heavy Drinking Among Deceased Donors does not Affect Recipient Outcomes After Liver Transplantation (2017) (0)
- P0031 : Frequency and outcomes of simultaneous liver kidney transplantation in NASH (2015) (0)
- Thrombotic complications in liver transplant recipients for Budd-Chiari syndrome (2000) (0)
- 224 Safety and potential efficacy of etanercept in patients with alcoholic hepatitis: analysis of a recently completed pilot study (2003) (0)
- The APPLE Association President's Message (2017) (0)
- Prognostic factors in severe autoimmune chrcnic active hepatitis (ACAH): Role of orthotopic liver transplantation(OLT) (1991) (0)
- B24 - Nocturnal hypertension after organ transplantation (TX) is mediated by systemic vasoconstriction and leads to pressure natriuresis (1995) (0)
- M021: Delayed recovery of circadian blood pressure (BP) rhythm after cardiac transplant (TX) compared to liver TX at one year (1998) (0)
- In a rapidly changing world, can we truly predict the impact of liver graft quality 15 years from now? (2015) (0)
- ASSOCIATION OF HEPATITIS C WITH SUBCLINICAL REACTIVATION OF HEPATITIS B VIRAL DNA DETECTED BY POLYMERASE CHAIN REACTION (PCR) IN ALLOGRAFTS OF RECIPIENTS WITH APPARENT IMMUNITY TO HEPATITIS B (1999) (0)
- THE EFFECT OF HLA-DR MATCH ON THE INCIDENCE OF NON-ANASTOMOTIC BILIARY STRICTURES AFTER LIVER TRANSPLANTATION. (1999) (0)
- Asymptomatic PSC—Do they really have progressive diseases? (1991) (0)
- Recurrence of primary biliary cirrhosis after liver transplantation: An update on incidence (2000) (0)
- Diagnosing and managing primary sclerosing cholangitis (1997) (0)
- Lack of an association between the HFE C282Y mutation and the alpha 1 antitrypsin allele in patients with end-stage liver disease (2003) (0)
- Su1012 Frequency and Outcomes of Simultaneous Liver Kidney Transplantation in NASH (2015) (0)
- The long-term outcome of liver transplant recipients with de novo hepatitis B infection who received an anti-HBC graft (2002) (0)
- Su1003 Post-Transplant Outcomes at MELD>40 Are Better for Patients Receiving Simultaneous Liver Kidney Compared to Liver Transplant Alone (2015) (0)
- Immunology of liver transplantation: Edited by James Neuberger and David Adams. 301 pp. $129.50. Little, Brown and Company, Boston, Massachusetts, 1993. ISBN 0-340-55310-3 (1994) (0)
- 208 Increased donor age is associated with increased risk of recurrent primary billiary cirrhosis following liver transplantation (2003) (0)
This paper list is powered by the following services: